A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease usually presenting after infection. Emerging evidence supports that energy metabolism is affected in ME/CFS, but a unifying metabolic phenotype has not been firmly established. We performed global metabolomics, lip...
Hlavní autoři: | Fredrik Hoel, August Hoel, Ina K.N. Pettersen, Ingrid G. Rekeland, Kristin Risa, Kine Alme, Kari Sørland, Alexander Fosså, Katarina Lien, Ingrid Herder, Hanne L. Thürmer, Merete E. Gotaas, Christoph Schäfer, Rolf K. Berge, Kristian Sommerfelt, Hans-Peter Marti, Olav Dahl, Olav Mella, Øystein Fluge, Karl J. Tronstad |
---|---|
Médium: | Článek |
Jazyk: | English |
Vydáno: |
American Society for Clinical investigation
2021-08-01
|
Edice: | JCI Insight |
Témata: | |
On-line přístup: | https://doi.org/10.1172/jci.insight.149217 |
Podobné jednotky
-
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients.
Autor: Ingrid G Rekeland, a další
Vydáno: (2022-01-01) -
Activity monitoring and patient-reported outcome measures in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome patients
Autor: Ingrid G. Rekeland, a další
Vydáno: (2022-01-01) -
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Autor: Ingrid G Rekeland, a další
Vydáno: (2024-01-01) -
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome–Results From Open-Label Cyclophosphamide Intervention Study
Autor: Kari Sørland, a další
Vydáno: (2021-03-01) -
B-Lymphocyte Depletion in Myalgic Encephalopathy/ Chronic Fatigue Syndrome. An Open-Label Phase II Study with Rituximab Maintenance Treatment.
Autor: Øystein Fluge, a další
Vydáno: (2015-01-01)